Coherus Oncology CHRS
NASDAQ CHRS
$0.75 +0.00 (+0.56%)
As of: Nov 6, 2026 · 9:54 AM EST

Coherus Oncology (CHRS) Change in Other Operating Liabilities (2013 - 2026)

Updated

Analysis

Coherus Oncology (CHRS) Change in Other Operating Liabilities (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,221.54 Bn 1,195.15 Bn 20.46 Bn -
2 Johnson & Johnson 650.21 Bn 570.07 Bn 17.30 Bn 2.69 Bn
3 AbbVie 508.24 Bn 476.24 Bn 13.12 Bn -
4 Merck 360.07 Bn 323.01 Bn 13.19 Bn -
5 Novartis Ag 312.26 Bn 285.49 Bn - -
6 Astrazeneca 285.31 Bn 259.20 Bn 13.26 Bn -
7 Amgen 247.74 Bn 199.39 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 207.12 Bn 182.22 Bn 6.73 Bn -
9 Pfizer 166.13 Bn 113.48 Bn 12.56 Bn -113.00 Mn
10 Coherus Oncology 116.17 Mn -519.97 Mn 10.07 Mn -734,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -734,000.00
Mar 31, 2026 -1.63 Mn
Dec 31, 2025 -30.21 Mn
Sep 30, 2025 -21.06 Mn
Jun 30, 2025 -50.92 Mn
Mar 31, 2025 -17.13 Mn
Dec 31, 2024 1.55 Mn
Sep 30, 2024 -14.14 Mn
Jun 30, 2024 21.68 Mn
Mar 31, 2024 -15.16 Mn
Dec 31, 2023 52.50 Mn
Sep 30, 2023 34.22 Mn
Jun 30, 2023 25.15 Mn
Mar 31, 2023 1.24 Mn
Dec 31, 2022 440,000.00
Sep 30, 2022 -10.53 Mn
Jun 30, 2022 -7.35 Mn
Mar 31, 2022 -7.13 Mn
Dec 31, 2021 -5.72 Mn
Sep 30, 2021 986,000.00
API Access

Coherus Oncology Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=CHRS&period=max&api_key=YOUR_API_KEY